Literature DB >> 875886

The use of RD cells in the isolation of Echo type 30 virus from patients with aseptic meningitis.

I Wecker.   

Abstract

Between early July and August 1976, 60 cases of aseptic meningitis and pharyngitis in children from various parts of West Germany were reported to this institute. Successful virus isolation from spinal fluid in 12 out of 36 cases was greatly facilitated by the use of RD cell tissue cultures, whereas isolation attempts in HEL, Vero, and HFDK cells were unsuccessful. In all cases, the isolated virus was identified as ECHO type 30. Neutralization studies with sera of 48 remaining cases also using RD cells clearly indicated that the epidemic outbreak was caused by ECHO type 30 virus.

Entities:  

Mesh:

Year:  1977        PMID: 875886     DOI: 10.1007/bf02126708

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  14 in total

1.  [Letter: Meningitis due to echo 30. Familial cases].

Authors:  G Obert; M Lab; J P Gut; A Kirn; M Jost
Journal:  Nouv Presse Med       Date:  1975-06-21

2.  Propagation and isolation of group A coxsackieviruses in RD cells.

Authors:  N J Schmidt; H H Ho; E H Lennette
Journal:  J Clin Microbiol       Date:  1975-09       Impact factor: 5.948

3.  THE GROWTH AND MAINTENANCE OF TISSUE-CELL CULTURES IN FREE GAS EXCHANGE WITH THE ATMOSPHERE.

Authors:  A LEIBOVITZ
Journal:  Am J Hyg       Date:  1963-09

4.  Typing of viruses by combinations of antiserum pools. Application to typing of enteroviruses (Coxsackie and ECHO).

Authors:  K A LIM; M BENYESH-MELNICK
Journal:  J Immunol       Date:  1960-03       Impact factor: 5.422

5.  [Letter: Meningitis epidemic due to Echo 30 (1974) virus].

Authors:  F A Denis; M Geslin; M F Hunault; M Sagnole
Journal:  Nouv Presse Med       Date:  1974-12-28

6.  Aseptic meningitis caused by Echo virus type 30.

Authors:  M Mozetic; R Zargi; M Matjasic
Journal:  Acta Med Iugosl       Date:  1973

7.  U.S. cases in 1968: epidemiology of echovirus 30 aseptic meningitis.

Authors:  W H Likosky; R W Emmons; L E Davis; R S Thompson
Journal:  Health Serv Rep       Date:  1972 Aug-Sep

8.  Echoviruses types 4 and 9 in an outbreak of aseptic meningitis in Jerusalem.

Authors:  A Moshkowitz; S Yatziv; A Russell; A Abrahamov; M Nishmi
Journal:  Scand J Infect Dis       Date:  1970

9.  [Epidemic due to Echo virus 30. II. Virological and epidemiological study].

Authors:  J Regnard; J L Moreno; G de St-Maur; P Lebon; J M Huraux; A Bouvier; F Bricout
Journal:  Ann Pediatr (Paris)       Date:  1970-12-02

10.  Four-year study of WHO virus reports on enteroviruses other than poliovirus.

Authors:  F Assaad; W C Cockburn
Journal:  Bull World Health Organ       Date:  1972       Impact factor: 9.408

View more
  5 in total

1.  Presumptive identification of enteroviruses with RD, HEp-2, and RMK cell lines.

Authors:  S L Johnston; C S Siegel
Journal:  J Clin Microbiol       Date:  1990-05       Impact factor: 5.948

2.  RD cells in the laboratory diagnosis of enteroviruses.

Authors:  I Wecker; V ter Meulen
Journal:  Med Microbiol Immunol       Date:  1977-12-27       Impact factor: 3.402

3.  Method for selecting optimal cells for enterovirus isolation as determined in an outbreak of echovirus type 33 meningitis.

Authors:  E Druyts-Voets; F Yane; E Bosmans; J Colaert; J Desmyter
Journal:  Eur J Clin Microbiol       Date:  1985-06       Impact factor: 3.267

4.  Routine enterovirus diagnosis in a human rhabdomyosarcoma cell line.

Authors:  E J Bell; B P Cosgrove
Journal:  Bull World Health Organ       Date:  1980       Impact factor: 9.408

5.  Epidemical and etiological study on hand, foot and mouth disease following EV-A71 vaccination in Xiangyang, China.

Authors:  Xiao-Dan Meng; Yeqing Tong; Zhen-Ni Wei; Lei Wang; Jian-Yi Mai; Yang Wu; Zhi-Yu Luo; Shaoping Li; Meng Li; Siquan Wang; Sheng Wei; Wensheng Gong; Wangsheng Zhang; Xingzhou Hu; Jiao Huang; Jing Shi; Gang Yang; Shengli Meng; Zejun Wang; Xuhua Guan; Shuo Shen
Journal:  Sci Rep       Date:  2020-12-01       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.